Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 875 of 1,261

  1. US 8426554

    In vivo polynucleotide delivery conjugates having enzyme sensitive linkages

    Arrowhead Madison, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  2. US 8426461

    Orally dispersible tablet

    Takeda Pharmaceutical Company Limited · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  3. US 8426458

    Hepatitis C Virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  4. US 8426444

    Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

    Lixte Biotechnology, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  5. US 8426445

    Iminosugars and methods of treating bunyaviral and togaviral diseases

    United Therapeutics Corporation · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  6. US 8426436

    Heterocyclic cyclopamine analogs and methods of use thereof

    Infinity Discovery, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  7. US 8426432

    Inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties

    UNIVERSITY OF CONNECTICUT · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  8. US 8426426

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  9. US 8426414

    Modulators of G protein-coupled receptor 88

    LEXICON PHARMACEUTICALS, INC. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  10. US 8425446

    Selective cytopheresis devices and related methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  11. US 8426379

    POT1 alternative splicing variants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  12. US 8426365

    Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  13. US 8425445

    Selective cytopheresis devices and related methods thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  14. US 8425933

    Abuse-resistant oral dosage forms and method of use thereof

    Elite Laboratories, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  15. US 8425930

    Prebiotic oligosaccharides

    The Regents of the University of California · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  16. US 8426188

    Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  17. US 8426179

    Synthetic peptide and peptide conjugates and related tissue coupling methods via transglutaminase enzyme

    Northwestern University · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  18. US 8425653

    Plasmon mediated photoinduced synthesis of silver triangular bipyramids

    Northwestern University · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  19. US 8426611

    7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof

    THERON PHARMACEUTICALS, INC. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  20. US 8425492

    In vivo device, system and usage thereof

    Julius-Maximilians-Universitat Wurzburg · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  21. US 8425459

    Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent

    Lutonix, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  22. US 8425447

    Selective cytopheresis devices and related methods thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  23. CA 2852995

    COMPOSITION OPHTALMIQUE QUI CONTIENT DU BROMFENAC PRESENTANT UNE BIODISPONIBILITE ACCRUE

    BAUSCH & LOMB [US] · Granted Apr 18, 2013 · Expires Apr 13, 2033

    granted

  24. US 8420368

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.